These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 349267)

  • 1. Systemic lymphoblastic response to antithymocyte globulin in renal allograft recipients: an initial report.
    Iwatsuki S; Geis WP; Molnar Z; Giacchino JL; Ing TS; Hano JE
    J Surg Res; 1978 May; 24(5):428-34. PubMed ID: 349267
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudolymphoma in renal allograft recipients.
    Geis WP; Iwatsuki S; Molnar Z; Giacchino JL; Kerman RH; Ing TS; Hano JE
    Arch Surg; 1978 Apr; 113(4):461-6. PubMed ID: 205191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithymocyte globulin (ATGAM) in renal allograft recipients. Multicenter trials using a 14-dose regimen.
    Wechter WJ; Brodie JA; Morrell RM; Rafi M; Schultz JR
    Transplantation; 1979 Oct; 28(4):294-302. PubMed ID: 388762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant lymphoma in a renal transplant recipient treated with antithymocyte globulin.
    Kheirbek AO; Molnar ZV; Choudhury A; Geis WP; Daugirdas JT; Hano JE; Ing TS
    Transplantation; 1983 Mar; 35(3):267-8. PubMed ID: 6340279
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of antithymocyte globulin (dose by rosette protocol) in pediatric renal allograft recipients.
    Uittenbogaart CH; Robinson BJ; Malekzadeh MH; Pennisi AJ; Ettenger RB; Fine RN
    Transplantation; 1979 Oct; 28(4):291-3. PubMed ID: 388761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.
    Soulillou JP; Cantarovich D; Le Mauff B; Giral M; Robillard N; Hourmant M; Hirn M; Jacques Y
    N Engl J Med; 1990 Apr; 322(17):1175-82. PubMed ID: 2157982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic monitoring of antithymocyte globulin treatment for acute allograft rejection.
    Delmonico FL; Nelson PW; Colvin RB; Cosimi AB
    Transplant Proc; 1984 Dec; 16(6):1492-3. PubMed ID: 6390852
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized clinical trial of antithymocyte globulin in cadaver renal allograft recipients: importance of T cell monitoring.
    Cosimi AB; Wortis HH; Delmonico FL; Russell PS
    Surgery; 1976 Aug; 80(2):155-63. PubMed ID: 781887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of equine antithymocyte globulin in recipients of renal allografts: Analysis of survival, renal function, rejection, histocompatibility, and complications.
    Diethelm AG; Aldrete JS; Shaw JF; Cobbs CG; Hartley MW; Sterling WA; Morgan JM
    Ann Surg; 1974 Jul; 180(1):20-8. PubMed ID: 4599406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of sudden deafness probably due to antithymocyte globulin treatment.
    Vural A; Onder T; Tanboğa H
    Nephron; 1995; 69(3):345. PubMed ID: 7753276
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical significance of T cell monitoring during antithymocyte globulin induction in renal transplantation.
    Thervet E; Chatenoud L; Legendre C; Mamzer-Bruneel MF; Kreis H; Bach JF
    Transplant Proc; 1997 Aug; 29(5):2330-1. PubMed ID: 9270748
    [No Abstract]   [Full Text] [Related]  

  • 12. Graft mucormycosis in a renal allograft recipient.
    Ahmad M
    J Nephrol; 2005; 18(6):783-6. PubMed ID: 16358241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithymocyte globulin therapy after renal transplantation at the Massachusetts General Hospital.
    Delmonico FL
    Transplant Proc; 1984 Aug; 16(4):979-82. PubMed ID: 6380062
    [No Abstract]   [Full Text] [Related]  

  • 14. Antirejection treatment with anti-thymocyte globulin in renal transplant recipients treated with cyclosporine as basic immunosuppression.
    Hoitsma AJ; Wetzels JF; Berden JH; Koene RA
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):12-3. PubMed ID: 3051578
    [No Abstract]   [Full Text] [Related]  

  • 15. Individualized monitoring and modulation of immune reactivity using standardized antithymocyte globulin (ATG).
    Thomas F; Mendez-Picon G; Thomas J; Lee HM
    Transplant Proc; 1979 Jun; 11(2):1429-30. PubMed ID: 382531
    [No Abstract]   [Full Text] [Related]  

  • 16. The adjunctive value of equine antithymocyte membrane globulin in a randomized study of patients undergoing cadaveric renal transplantation.
    Diethelm AG; Blackstone E; Whelchel JD; Pass RF; Chambers L; Phillips SJ; Thiry C
    Transplant Proc; 1979 Mar; 11(1):27-30. PubMed ID: 377644
    [No Abstract]   [Full Text] [Related]  

  • 17. Extended treatment with antithymocyte globulin (ATGAM) in renal allograft recipients.
    Wechter WJ; Morrell RM; Bergan J; Rosenberg JC; Turcotte J; Schultz JR
    Transplantation; 1979 Nov; 28(5):365-7. PubMed ID: 392832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Minnesota antilymphoblast globulin and Upjohn antithymocyte globulin for induction immunosuppression of human renal allografts.
    Pescovitz MD; Book BK; Milgrom ML; Leapman SB; Petersen B; Filo RS
    Surgery; 1994 Oct; 116(4):811-8. PubMed ID: 7940183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithymocyte globulin-induced prolongation of human renal allograft survival in recipients with in vitro steroid-resistant ADCC.
    Dumble LJ; Clunie GJ; Macdonald IM; Bowes LG; Kincaid-Smith P
    Transplant Proc; 1984 Dec; 16(6):1503-5. PubMed ID: 6390854
    [No Abstract]   [Full Text] [Related]  

  • 20. Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection.
    Sollinger H; Kaplan B; Pescovitz MD; Philosophe B; Roza A; Brayman K; Somberg K
    Transplantation; 2001 Dec; 72(12):1915-9. PubMed ID: 11773888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.